News
Aspen Pharmacare, Johnson & Johnson announce deal to produce COVID-19 vaccine candidate
South African pharmaceutical company Aspen Pharmacare on Tuesday announced its deal with the American firm Johnson & Johnson to jointly manufacture its COVID-19 vaccine candidate...
News
CureVac COVID-19 vaccine induces immune response in early trial
German vaccine maker CureVac on Monday said that interim results from early trials showed that its investigational Covid-19 vaccine candidate, CvnCoV, appeared safe and triggered...
News
Bharat Biotech to launch candidate in Q2 2021, Israel starts human trials
The number of cases of the coronavirus disease (Covid-19) is nearing the 50 million mark across the world and the death toll has risen to...
News
Lonza Welcomes New Group Chief Executive Officer Pierre-Alain Ruffieux
Pierre-Alain Ruffieux today joins Lonza Group in the role of Chief Executive Officer. Albert Baehny has taken the role of CEO ad interim since November...
News
Novartis, Molecular Partners team up to develop DARPin therapeutics for COVID-19
Novartis and Molecular Partners AG announced a collaboration in the form of an option and license agreement to develop, manufacture and commercialize Molecular Partners’ anti-COVID-19...
News
Samsung Biologics and Checkpoint Therapeutics Expand Manufacturing Partnership for Cosibelimab
Samsung Biologics Co., Ltd. and Checkpoint Therapeutics, Inc. announced the expansion of a long-term manufacturing partnership for Checkpoint’s anti-PD-L1 antibody, cosibelimab. Building upon an existing...
News
Wistar Scientists Creates a New Synthetic DNA Vaccine Against Powassan Virus
Scientists at The Wistar Institute have designed and tested the first-of-its-kind synthetic DNA vaccine against Powassan virus (POWV), targeting portions of the virus envelope protein....
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.